Switch Therapeutics
PrivateLast Round
Series A
Mar 14, 2023
Total Funding Raised
$71.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Switch Therapeutics is a biotechnology company that develops biomarker-gated genetic medicines using its proprietary Conditionally Activated siRNA (CASi) platform to treat central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Switch Therapeutics Comparables
Compare Switch Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atalanta Therapeutics | 82% | |
| Cargene Therapeutics | 81% | |
| Cenos Therapeutics | 81% | |
Switch Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 14, 2023 | ||||
| Seed | Oct 4, 2022 |
Key People
Founding team and executive leadership
Switch Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCB Ventures | Series A |
| KMG Capital Partners | Seed |
| Dolby Family Ventures | Series A |
| Digitalis Ventures | Series A |
| Upfront Ventures | Series A, Seed |
| UCB Ventures | Series A |
| Freeflow Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 212% MoM, reaching 1.8K.
- Mar 14, 2023
$52M round led by UCB Ventures and Insight Partners.
Switch Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Switch Therapeutics's valuation, stock price, and market status.